SCHEMBL926644

SCHEMBL926644

CC(C)(C)Oc1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.45
POLB P06746 2/20 0.45
APOBEC3A P31941 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MMP8 P22894 4/20 0.43
MCL1 Q07820 3/20 0.43
MMP3 P08254 2/20 0.43
BCL2L1 Q07817 1/20 0.43
BAK1 Q16611 1/20 0.43
GAA P10253 2/20 0.43
PTGER3 P43115 1/20 0.43
ESR1 P03372 1/20 0.42
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926646 0.90 NPSR1 (0.49) NPSR1ALDH1A1LMNAL3MBTL1POLB
SCHEMBL926563 0.89 NPSR1 (0.48) NPSR1ALDH1A1LMNAL3MBTL1POLB
SCHEMBL8380984 0.87 ALDH1A1 (0.53) NPSR1ALDH1A1LMNAL3MBTL1MCL1
SCHEMBL644252 0.87 ALDH1A1 (0.53) NPSR1ALDH1A1LMNAL3MBTL1MCL1
SCHEMBL3591921 0.85 LMNA (0.50) NPSR1ALDH1A1LMNAL3MBTL1POLB
SCHEMBL926085 0.85 LMNA (0.50) NPSR1ALDH1A1LMNAL3MBTL1POLB
SCHEMBL927146 0.84 ALDH1A1 (0.50) NPSR1ALDH1A1LMNAL3MBTL1POLB
SCHEMBL28751377 0.84 LMNA (0.52) NPSR1ALDH1A1LMNAL3MBTL1POLB
SCHEMBL18041161 0.83 LMNA (0.67) NPSR1ALDH1A1LMNAL3MBTL1POLB
SCHEMBL15280427 0.83 LMNA (0.67) NPSR1ALDH1A1LMNAL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD NPSR1 297/4885ALDH1A1 2845/4885LMNA 1809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.